ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,282 | -11.7% | 1,300 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $39,962 | -14.7% | 1,300 | 0.0% | 0.01% | -12.5% |
| Q1 2023 | $46,839 | -12.9% | 1,300 | -4.4% | 0.01% | -11.1% |
| Q4 2022 | $53,747 | -0.5% | 1,360 | 0.0% | 0.01% | -10.0% |
| Q3 2022 | $54,000 | -6.9% | 1,360 | -0.3% | 0.01% | -9.1% |
| Q2 2022 | $58,000 | +13.7% | 1,364 | +4.9% | 0.01% | +22.2% |
| Q1 2022 | $51,000 | -1.9% | 1,300 | 0.0% | 0.01% | -10.0% |
| Q4 2021 | $52,000 | +10.6% | 1,300 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $47,000 | -11.3% | 1,300 | 0.0% | 0.01% | -9.1% |
| Q2 2021 | $53,000 | -7.0% | 1,300 | 0.0% | 0.01% | -21.4% |
| Q1 2021 | $57,000 | -12.3% | 1,300 | 0.0% | 0.01% | -17.6% |
| Q4 2020 | $65,000 | – | 1,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
| Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
| Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
| HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
| Brown University | 621,759 | $24,777,000 | 6.04% |
| Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
| Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
| Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |